Comparison Chart GI Innovation, Inc.

Stocks

A358570

KR7358570000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-08-28			5-day change	1st Jan Change
8,090.00 ^KRW	+0.87%		+6.03%	-54.14%

04-23	GI Innovation Enters Melanoma First-Line Treatment Market with GI-102 Approval for Phase 2 Clinical Trial Direct Comparison with Keytruda	CI
03-20	GI Innovation And Johnson & Johnson Enter Clinical Supply Agreement For Prostate Cancer Combination Therapy	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	GI INNOVATION, INC.	Other Biotechnology & Medical Research	+0.87%	+6.03%	-54.14%	-51.53%	-	379M